| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Codeine measurement |
Component |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Accidental codeine poisoning |
Causative agent (attribute) |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Intentional poisoning by codeine |
Causative agent (attribute) |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Poisoning caused by codeine of undetermined intent |
Causative agent (attribute) |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Codeine adverse reaction |
Causative agent (attribute) |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to codeine |
Causative agent (attribute) |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Overdose of codeine |
Causative agent (attribute) |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Accidental overdose by codeine |
Causative agent (attribute) |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Intentional overdose by codeine |
Causative agent (attribute) |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| surdose de codéine d'intention indéterminée |
Causative agent (attribute) |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Urine codeine measurement |
Component |
False |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Codeine phosphate [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 15mg/5mL linctus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 15mg/5mL diabetic linctus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 3mg/5mL pediatric linctus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 15mg/5mL s/f linctus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate [analgesic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 25mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| phosphate de codéine 60 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Codeine linctus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Bromodiphenhydramine+codeine 12.5mg/5mL/10 mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 4.56mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 5mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Acetaminophen + alcohol + codeine phosphate 120mg/7%vv/12mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Acetaminophen + codeine phosphate 120mg/12mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 15 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 30 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate + promethazine hydrochloride 10mg/6.25mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 30mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Poisoning by codeine |
Causative agent (attribute) |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Product containing codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Aspirin 325 mg and carisoprodol 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and carisoprodol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and butalbital and caffeine and codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Acetaminophen + alcohol + codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing butalbital and caffeine and codeine phosphate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and carisoprodol and codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate + promethazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing bromazine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate+kaolin 10mg/3g/10mL mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 30 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Accidental poisoning by codeine |
Causative agent (attribute) |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Acetaminophen + codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Urine codeine screening |
Component |
False |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Product containing aspirin and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Product containing codeine and phenylephrine and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
| Product containing codeine and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Product containing chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
| Product containing codeine and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlorphenamine and codeine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
3 |
| Product containing codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and codeine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Aspirin 325 mg and codeine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 12.5 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 12.8 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Ibuprofen+codeine phosphate 300mg/20mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Ibuprofen+codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine sulfate |
Is a |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate |
Is a |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Intentional poisoning by codeine |
Causative agent (attribute) |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Aspirin + codeine 400mg/8mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Accidental poisoning by codeine |
Causative agent (attribute) |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Aspirin + codeine 500mg/8mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing codeine and terpin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Aspirin 300 mg and codeine 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing codeine and guaiacol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Product containing codeine and ibuprofen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Codeine phosphate+kaolin 10mg/3g/10mL mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Phenylephrine 5mg/promethazine 6.25mg/codeine 10mg in 5mL oral syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
|
| Product containing codeine and kaolin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Product containing codeine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of codeine in saliva specimen (procedure) |
Component |
False |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Allergy to codeine |
Causative agent (attribute) |
False |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Aspirin 300 mg and codeine 8 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Aspirin 325 mg and codeine 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Aspirin 325 mg and codeine 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Codeine (substance) |
Inferred relationship |
Some |
2 |
| Aspirin 300 mg and codeine 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 300 mg and codeine 8 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and codeine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and codeine 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Codeine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]